National Institute for Health Research: RSV - Winter Virus Injection Could Cut Baby Hospitalisations by 80%
January 06, 2024
January 06, 2024
LONDON, England, Jan. 6 (TNSres) -- The National Institute for Health Research issued the following news:
A new antibody treatment to protect babies against a common winter virus could reduce hospitalisations by more than 80%, according to an international trial.
The HARMONIE trial is a collaboration between global pharmaceutical company Sanofi, its partner AstraZeneca and the NIHR. It involved 8,058 babies aged under 12 months from the UK, France and Germany. The babie . . .
A new antibody treatment to protect babies against a common winter virus could reduce hospitalisations by more than 80%, according to an international trial.
The HARMONIE trial is a collaboration between global pharmaceutical company Sanofi, its partner AstraZeneca and the NIHR. It involved 8,058 babies aged under 12 months from the UK, France and Germany. The babie . . .